TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 73 filers reported holding TANGO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,102,632 | +263.6% | 2,939,843 | +7.2% | 0.00% | – |
| Q2 2023 | $9,104,168 | -16.2% | 2,742,219 | -0.3% | 0.00% | – |
| Q1 2023 | $10,862,193 | -44.8% | 2,749,922 | +1.3% | 0.00% | -100.0% |
| Q4 2022 | $19,682,387 | +108.8% | 2,714,812 | +4.3% | 0.00% | – |
| Q3 2022 | $9,426,000 | -30.9% | 2,603,744 | -13.6% | 0.00% | – |
| Q2 2022 | $13,644,000 | -33.7% | 3,011,918 | +11.0% | 0.00% | – |
| Q1 2022 | $20,571,000 | +30.0% | 2,713,963 | +87.6% | 0.00% | – |
| Q4 2021 | $15,829,000 | -11.6% | 1,446,765 | +4.5% | 0.00% | – |
| Q3 2021 | $17,906,000 | – | 1,384,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $146,779,000 | 53.77% |
| TCG Crossover Management, LLC | 1,254,500 | $9,509,000 | 3.82% |
| Cormorant Asset Management, LP | 4,899,185 | $37,136,000 | 2.85% |
| Boxer Capital, LLC | 6,871,642 | $52,087,000 | 2.68% |
| Casdin Capital, LLC | 5,487,910 | $41,598,000 | 1.86% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $14,567,000 | 1.42% |
| Samsara BioCapital, LLC | 630,000 | $4,775,000 | 1.20% |
| TANG CAPITAL MANAGEMENT LLC | 468,750 | $3,553,000 | 0.71% |
| Southpoint Capital Advisors LP | 3,805,929 | $28,849,000 | 0.56% |
| HARVARD MANAGEMENT CO INC | 708,385 | $5,370,000 | 0.54% |